10940 Wilshire Blvd, Suite 1600, Los Angeles, CA 90024
7765 Lake Worth Road, Suite 311, Wellington, FL 33467
Research library
WallStreet Research has published hundreds of reports over five decades, distributed to over 200,000 investor subscribers worldwide. These are the reports and profiles featured online, covering emerging growth companies on NASDAQ, NYSE, AMEX, OTC Markets, TSX, CSE and global exchanges.
An international biopharmaceutical company in New York City with operations in the U.S. and China, developing cellular therapies in oncology, immunology and regenerative medicine. It also provides adult stem cell and cord blood collection, processing and storage services.
A holding company in Wayne, Pennsylvania, that builds value in growth-stage technology and life sciences businesses by providing capital and strategic, operational and management support. Its track record includes Novell, QVC and Cambridge Technology Partners.
Develops and licenses hormone therapy products, focusing on transdermal gels that deliver bioidentical estradiol and testosterone. Its lead products include Elestrin, an FDA-approved gel for menopausal symptoms, and LibiGel for female sexual dysfunction.
A specialty pharmaceutical company in Hayward, California, serving the acute care and critical care hospital markets. Formed in 1999 through the merger of RiboGene and Cypros Pharmaceutical, it markets four acute care products and has critical care drugs in clinical development.
WallStreet Research provides research services to publicly traded companies on a fee basis, the nature and amount of which is fully disclosed in each report. Read the Disclaimer
